vasoactive-intestinal-peptide and Hypogonadism

vasoactive-intestinal-peptide has been researched along with Hypogonadism* in 1 studies

Other Studies

1 other study(ies) available for vasoactive-intestinal-peptide and Hypogonadism

Article	Year
Decreased vasoactive intestinal polypeptide (VIP) level in cerebrospinal fluid from diabetic patients with neuropathy. Fukuoka igaku zasshi = Hukuoka acta medica, 1991, Volume: 82, Issue:1 The concentration of vasoactive intestinal polypeptide (VIP) was measured in cerebrospinal fluid (CSF) obtained from diabetic patients with neuropathy and their age-matched control subjects. VIP level in CSF from diabetic patients was significantly decreased as compared with that from the controls (12.9 +/- 3.1 pg/ml vs. 35.4 +/- 3.3 pg/ml, p less than 0.01). Decreased VIP level in CSF may relate with diabetic neuropathy in particular sexual dysfunction. Topics: Adult; Diabetic Neuropathies; Humans; Hypogonadism; Male; Middle Aged; Radioimmunoassay; Vasoactive Intestinal Peptide	1991

Article

Year

Decreased vasoactive intestinal polypeptide (VIP) level in cerebrospinal fluid from diabetic patients with neuropathy.

Fukuoka igaku zasshi = Hukuoka acta medica, 1991, Volume: 82, Issue:1

The concentration of vasoactive intestinal polypeptide (VIP) was measured in cerebrospinal fluid (CSF) obtained from diabetic patients with neuropathy and their age-matched control subjects. VIP level in CSF from diabetic patients was significantly decreased as compared with that from the controls (12.9 +/- 3.1 pg/ml vs. 35.4 +/- 3.3 pg/ml, p less than 0.01). Decreased VIP level in CSF may relate with diabetic neuropathy in particular sexual dysfunction.

Topics: Adult; Diabetic Neuropathies; Humans; Hypogonadism; Male; Middle Aged; Radioimmunoassay; Vasoactive Intestinal Peptide

1991